BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 21867748)

  • 1. Molecular assay optimized by Taguchi experimental design method for venous thromboembolism investigation.
    Celani de Souza HJ; Moyses CB; Pontes FJ; Duarte RN; Sanches da Silva CE; Alberto FL; Ferreira UR; Silva MB
    Mol Cell Probes; 2011; 25(5-6):231-7. PubMed ID: 21867748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid triplex asymmetric real-time PCR hybridization probe assay for the joint genotyping of F2, F5 and F12.
    Martínez-Serra J; Gutierrez A; Amat JC; Galmés B; Vila A; Julia M; López H; Bautista AM; Truyols C; Ros T; Navarro M; Canaro M; Díaz M; Besalduch J
    Clin Biochem; 2009 Aug; 42(12):1317-24. PubMed ID: 19422815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct blood PCR: TaqMan-probe based detection of the venous thromboembolism associated mutations factor V Leiden and prothrombin c.20210G>A without DNA extraction.
    Geiger K; Leiherer A; Brandtner EM; Fraunberger P; Drexel H; Muendlein A
    Clin Chim Acta; 2019 Jan; 488():221-225. PubMed ID: 30439355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of methods for detection of factor V Leiden and the prothrombin G20210A mutations.
    Cooper PC; Rezende SM
    Int J Lab Hematol; 2007 Jun; 29(3):153-62. PubMed ID: 17474891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Roche LightCycler: a simple and rapid method for direct detection of factor V Leiden and prothrombin G20210A genotypes from blood samples without the need for DNA extraction.
    Cooper PC; Cooper SM; Smith JM; Kitchen S; Makris M
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):499-503. PubMed ID: 12851538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous detection of FV Q506 and prothrombin 20210 A variation by allele-specific PCR.
    Mitterer M; Lanthaler AJ; Mair W; Giacomuzzi K; Coser P
    Haematologica; 1999 Mar; 84(3):204-7. PubMed ID: 10189382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
    Chaireti R; Jennersjö C; Lindahl TL
    Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
    Coen D; Zadro R; Honović L; Banfić L; Stavljenić Rukavina A
    Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined factor V leiden (G1691A) and prothrombin (G20210A) genotyping by multiplex real-time polymerase chain reaction using fluorescent resonance energy transfer hybridization probes on the Rotor-Gene 2000.
    Ameziane N; Lamotte M; Lamoril J; Lebret D; Deybach JC; Kaiser T; de Prost D
    Blood Coagul Fibrinolysis; 2003 Jun; 14(4):421-4. PubMed ID: 12945887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.
    Gerhardt A; Scharf RE; Beckmann MW; Struve S; Bender HG; Pillny M; Sandmann W; Zotz RB
    N Engl J Med; 2000 Feb; 342(6):374-80. PubMed ID: 10666427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
    Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
    J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry.
    Gadelha T; Roldán V; Lecumberri R; Trujillo-Santos J; del Campo R; Poggio R; Monreal M;
    Thromb Res; 2010 Oct; 126(4):283-6. PubMed ID: 20627204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-color multiplex 5' nuclease assay for the simultaneous detection of the factor V Leiden and the prothrombin G20210A mutations.
    Ugozzoli LA; Hamby K
    Mol Cell Probes; 2004 Jun; 18(3):161-6. PubMed ID: 15135449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Factor V Leiden and prothrombin c.20210G>A allele by Roche Diagnostics LightCycler®.
    Cooper PC
    Methods Mol Biol; 2011; 688():239-55. PubMed ID: 20938843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study between the Light Cycler and the PCR-restriction fragment length polymorphism in detecting factor V Leiden and factor II 20210G>A mutations.
    Mammo L; Sheereen A; Saour T; Saour J
    Clin Biochem; 2006 Jul; 39(7):767-9. PubMed ID: 16563366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
    Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.